Evidence map›Paper›PMID 38808669›Full record

ArticleNucleic acids research2024

Biochemical properties of chromatin domains define genome compartmentalization.

Federica Lucini, Cristiano Petrini, Elisa Salviato, Koustav Pal, Valentina Rosti, Francesca Gorini, Philina Santarelli, Roberto Quadri, Giovanni Lembo, Giulia Graziano and 9 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. The molecular basis of lamin-specific chromatin interactions.Nature structural & molecular biology · 2025
    Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Federica LuciniINGM, Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.ORCID 0000-0001-8515-193X
Cristiano PetriniIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan 20139, Italy.
Elisa SalviatoIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan 20139, Italy.ORCID 0000-0003-3246-7820
Koustav PalIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan 20139, Italy.
Valentina RostiINGM, Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.
Francesca GoriniINGM, Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.
Philina SantarelliINGM, Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.
Roberto QuadriINGM, Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.
Giovanni LemboIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan 20139, Italy.
Giulia GrazianoIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan 20139, Italy.
Emanuele Di Patrizio SoldateschiINGM, Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.
Ilario TagliaferriIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan 20139, Italy.
Eva PinatelITB-CNR, Institute of Biomedical Technologies, National Research Council, Segrate 20054, Italy.
Endre SebestyénIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan 20139, Italy.
Luca RottaIEO, European Institute of Oncology IRCCS, Milan 20141, Italy.
Francesco GentileFondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan 20122, Italy.
Valentina VairaDivision of Pathology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Chiara LanzuoloINGM, Istituto Nazionale di Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan 20122, Italy.ORCID 0000-0003-2649-6334
Francesco FerrariIFOM-ETS, The AIRC Institute of Molecular Oncology, Milan 20139, Italy.ORCID 0000-0002-9811-3753

Funding

AIRC 26942AIRC Start-Up 16841Cariplo Foundation 2017-0649FRRB INTERSTRAT-CAD CP2_14/2018MFAG 18535PRF 2021-81Telethon GJC21144A
6 · The paper itself

Abstract

Chromatin three-dimensional (3D) organization inside the cell nucleus determines the separation of euchromatin and heterochromatin domains. Their segregation results in the definition of active and inactive chromatin compartments, whereby the local concentration of associated proteins, RNA and DNA results in the formation of distinct subnuclear structures. Thus, chromatin domains spatially confined in a specific 3D nuclear compartment are expected to share similar epigenetic features and biochemical properties, in terms of accessibility and solubility. Based on this rationale, we developed the 4f-SAMMY-seq to map euchromatin and heterochromatin based on their accessibility and solubility, starting from as little as 10 000 cells. Adopting a tailored bioinformatic data analysis approach we reconstruct also their 3D segregation in active and inactive chromatin compartments and sub-compartments, thus recapitulating the characteristic properties of distinct chromatin states. A key novelty of the new method is the capability to map both the linear segmentation of open and closed chromatin domains, as well as their compartmentalization in one single experiment.

Indexed as

EuchromatinHeterochromatinAnimalsCell NucleusChromatinDNAHumansChromatinDNAEuchromatinHeterochromatin

Identifiers

PMID38808669
PMCPMC11229364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.